Justice Department Announces Resolution Of Criminal And Civil Investigations Into McKinsey & Company’s Work With Purdue Pharma L.P.; Former McKinsey Senior Partner Charged With[...]

Justice Department Announces Resolution Of Criminal And Civil Investigations Into McKinsey & Company's Work With Purdue Pharma L.P.; Former McKinsey Senior Partner Charged With Obstruction Of Justice

McKinsey Will Pay $650 Million, Cease Work Relating to Controlled Substances and Implement Significant New Compliance Measures

McKinsey & Company Inc. (McKinsey), a global management consulting firm based in New York, has agreed to pay $650 million to resolve a criminal and civil investigation into the firm's consulting work with opioids manufacturer Purdue Pharma L.P. (Purdue). The resolution pertains to McKinsey's advice to Purdue concerning the sales and marketing of Purdue's extended-release opioid drug, OxyContin, including a 2013 engagement in which McKinsey advised on steps to "turbocharge" sales of OxyContin.

Read more on www.justice.gov

Share